Cost-effectiveness analysis of the diarrhea alleviation through zinc and oral rehydration therapy (DAZT) program in rural Gujarat India: an application of the net-benefit regression framework
Background This study evaluates the cost-effectiveness of the DAZT program for scaling up treatment of acute child diarrhea in Gujarat India using a net-benefit regression framework. Methods Costs were calculated from societal and caregivers’ perspectives and effectiveness was assessed in terms of c...
Saved in:
| Published in: | Cost effectiveness and resource allocation Vol. 15; no. 1; pp. 9 - 15 |
|---|---|
| Main Authors: | , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
London
BioMed Central
08.06.2017
BioMed Central Ltd Springer Nature B.V BMC |
| Subjects: | |
| ISSN: | 1478-7547, 1478-7547 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Background
This study evaluates the cost-effectiveness of the DAZT program for scaling up treatment of acute child diarrhea in Gujarat India using a net-benefit regression framework.
Methods
Costs were calculated from societal and caregivers’ perspectives and effectiveness was assessed in terms of coverage of zinc and both zinc and Oral Rehydration Salt. Regression models were tested in simple linear regression, with a specified set of covariates, and with a specified set of covariates and interaction terms using linear regression with endogenous treatment effects was used as the reference case.
Results
The DAZT program was cost-effective with over 95% certainty above $5.50 and $7.50 per appropriately treated child in the unadjusted and adjusted models respectively, with specifications including interaction terms being cost-effective with 85–97% certainty.
Discussion
Findings from this study should be combined with other evidence when considering decisions to scale up programs such as the DAZT program to promote the use of ORS and zinc to treat child diarrhea. |
|---|---|
| AbstractList | Background
This study evaluates the cost-effectiveness of the DAZT program for scaling up treatment of acute child diarrhea in Gujarat India using a net-benefit regression framework.
Methods
Costs were calculated from societal and caregivers’ perspectives and effectiveness was assessed in terms of coverage of zinc and both zinc and Oral Rehydration Salt. Regression models were tested in simple linear regression, with a specified set of covariates, and with a specified set of covariates and interaction terms using linear regression with endogenous treatment effects was used as the reference case.
Results
The DAZT program was cost-effective with over 95% certainty above $5.50 and $7.50 per appropriately treated child in the unadjusted and adjusted models respectively, with specifications including interaction terms being cost-effective with 85–97% certainty.
Discussion
Findings from this study should be combined with other evidence when considering decisions to scale up programs such as the DAZT program to promote the use of ORS and zinc to treat child diarrhea. This study evaluates the cost-effectiveness of the DAZT program for scaling up treatment of acute child diarrhea in Gujarat India using a net-benefit regression framework. Costs were calculated from societal and caregivers' perspectives and effectiveness was assessed in terms of coverage of zinc and both zinc and Oral Rehydration Salt. Regression models were tested in simple linear regression, with a specified set of covariates, and with a specified set of covariates and interaction terms using linear regression with endogenous treatment effects was used as the reference case. The DAZT program was cost-effective with over 95% certainty above $5.50 and $7.50 per appropriately treated child in the unadjusted and adjusted models respectively, with specifications including interaction terms being cost-effective with 85-97% certainty. Findings from this study should be combined with other evidence when considering decisions to scale up programs such as the DAZT program to promote the use of ORS and zinc to treat child diarrhea. Abstract Background This study evaluates the cost-effectiveness of the DAZT program for scaling up treatment of acute child diarrhea in Gujarat India using a net-benefit regression framework. Methods Costs were calculated from societal and caregivers’ perspectives and effectiveness was assessed in terms of coverage of zinc and both zinc and Oral Rehydration Salt. Regression models were tested in simple linear regression, with a specified set of covariates, and with a specified set of covariates and interaction terms using linear regression with endogenous treatment effects was used as the reference case. Results The DAZT program was cost-effective with over 95% certainty above $5.50 and $7.50 per appropriately treated child in the unadjusted and adjusted models respectively, with specifications including interaction terms being cost-effective with 85–97% certainty. Discussion Findings from this study should be combined with other evidence when considering decisions to scale up programs such as the DAZT program to promote the use of ORS and zinc to treat child diarrhea. Background This study evaluates the cost-effectiveness of the DAZT program for scaling up treatment of acute child diarrhea in Gujarat India using a net-benefit regression framework. Methods Costs were calculated from societal and caregivers' perspectives and effectiveness was assessed in terms of coverage of zinc and both zinc and Oral Rehydration Salt. Regression models were tested in simple linear regression, with a specified set of covariates, and with a specified set of covariates and interaction terms using linear regression with endogenous treatment effects was used as the reference case. Results The DAZT program was cost-effective with over 95% certainty above$5.50 and $ 7.50 per appropriately treated child in the unadjusted and adjusted models respectively, with specifications including interaction terms being cost-effective with 85-97% certainty. Discussion Findings from this study should be combined with other evidence when considering decisions to scale up programs such as the DAZT program to promote the use of ORS and zinc to treat child diarrhea. Keywords: Diarrhea, Cost-effectiveness, Net-benefit regression, Zinc, Oral rehydration salts, India, Developing countries, Implementation science Background This study evaluates the cost-effectiveness of the DAZT program for scaling up treatment of acute child diarrhea in Gujarat India using a net-benefit regression framework. Methods Costs were calculated from societal and caregivers’ perspectives and effectiveness was assessed in terms of coverage of zinc and both zinc and Oral Rehydration Salt. Regression models were tested in simple linear regression, with a specified set of covariates, and with a specified set of covariates and interaction terms using linear regression with endogenous treatment effects was used as the reference case. Results The DAZT program was cost-effective with over 95% certainty above $5.50 and $7.50 per appropriately treated child in the unadjusted and adjusted models respectively, with specifications including interaction terms being cost-effective with 85-97% certainty. Discussion Findings from this study should be combined with other evidence when considering decisions to scale up programs such as the DAZT program to promote the use of ORS and zinc to treat child diarrhea. This study evaluates the cost-effectiveness of the DAZT program for scaling up treatment of acute child diarrhea in Gujarat India using a net-benefit regression framework. Costs were calculated from societal and caregivers' perspectives and effectiveness was assessed in terms of coverage of zinc and both zinc and Oral Rehydration Salt. Regression models were tested in simple linear regression, with a specified set of covariates, and with a specified set of covariates and interaction terms using linear regression with endogenous treatment effects was used as the reference case. The DAZT program was cost-effective with over 95% certainty above$5.50 and $ 7.50 per appropriately treated child in the unadjusted and adjusted models respectively, with specifications including interaction terms being cost-effective with 85-97% certainty. This study evaluates the cost-effectiveness of the DAZT program for scaling up treatment of acute child diarrhea in Gujarat India using a net-benefit regression framework.BACKGROUNDThis study evaluates the cost-effectiveness of the DAZT program for scaling up treatment of acute child diarrhea in Gujarat India using a net-benefit regression framework.Costs were calculated from societal and caregivers' perspectives and effectiveness was assessed in terms of coverage of zinc and both zinc and Oral Rehydration Salt. Regression models were tested in simple linear regression, with a specified set of covariates, and with a specified set of covariates and interaction terms using linear regression with endogenous treatment effects was used as the reference case.METHODSCosts were calculated from societal and caregivers' perspectives and effectiveness was assessed in terms of coverage of zinc and both zinc and Oral Rehydration Salt. Regression models were tested in simple linear regression, with a specified set of covariates, and with a specified set of covariates and interaction terms using linear regression with endogenous treatment effects was used as the reference case.The DAZT program was cost-effective with over 95% certainty above $5.50 and $7.50 per appropriately treated child in the unadjusted and adjusted models respectively, with specifications including interaction terms being cost-effective with 85-97% certainty.RESULTSThe DAZT program was cost-effective with over 95% certainty above $5.50 and $7.50 per appropriately treated child in the unadjusted and adjusted models respectively, with specifications including interaction terms being cost-effective with 85-97% certainty.Findings from this study should be combined with other evidence when considering decisions to scale up programs such as the DAZT program to promote the use of ORS and zinc to treat child diarrhea.DISCUSSIONFindings from this study should be combined with other evidence when considering decisions to scale up programs such as the DAZT program to promote the use of ORS and zinc to treat child diarrhea. |
| ArticleNumber | 9 |
| Audience | Academic |
| Author | LeFevre, Amnesty E. Taneja, Sunita Mazumder, Sarmila Fischer-Walker, Christa L. Black, Robert E. Shillcutt, Samuel D. |
| Author_xml | – sequence: 1 givenname: Samuel D. surname: Shillcutt fullname: Shillcutt, Samuel D. organization: Department of International Health, Johns Hopkins Bloomberg School of Public Health – sequence: 2 givenname: Amnesty E. surname: LeFevre fullname: LeFevre, Amnesty E. email: aelefevre@gmail.com organization: Department of International Health, Johns Hopkins Bloomberg School of Public Health – sequence: 3 givenname: Christa L. surname: Fischer-Walker fullname: Fischer-Walker, Christa L. organization: Department of International Health, Johns Hopkins Bloomberg School of Public Health – sequence: 4 givenname: Sunita surname: Taneja fullname: Taneja, Sunita organization: Centre for Health Research and Development, Society for Applied Studies – sequence: 5 givenname: Robert E. surname: Black fullname: Black, Robert E. organization: Department of International Health, Johns Hopkins Bloomberg School of Public Health – sequence: 6 givenname: Sarmila surname: Mazumder fullname: Mazumder, Sarmila organization: Centre for Health Research and Development, Society for Applied Studies |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28603456$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9ks1u1DAURiNURH_gAdggS2zKIsVOHNthgTQqUCpVYlM2bCzHucl4yNiDnRQNL8ercdNpoa0AZeHIPt-xr30Psz0fPGTZc0ZPGFPidWJFLYqcMplTKmm-fZQdMC5VLisu9-7872eHKa0oLcqCqifZfqEELXklDrKfpyGNOXQd2NFdgYeUiPFm2CaXSOjIuATSOhPjEgwxwwBXzowueFyIYeqX5IfzFhMtCdEMJMJy28ZbAqLZbMnxu8WXy1dkE0MfzZo4T-I0s2fTyiBKzj1u8AYdxGw2g7O79M3eHsa8wWN1bkR5H_F882qHJvge4ten2ePODAme3YxH2ecP7y9PP-YXn87OTxcXucVKx5xZ1TYWik5WknMFdWnKppUlF1IypVgpGqmEgBoZK0qrhGyNsQ1tm8IYhI-y8523DWalN9GtTdzqYJy-ngix1yaOzg6guUVtXXYtp4rzslJV3YCxBljBLNQ1ut7uXJupWUNrwY94H_ek91e8W-o-XOmKi6qqZsHxjSCGbxOkUa9dsjAMxkOYkmY1VbJWjAlEXz5AV2GK-MAzxSrORCH5H6o3WIDzXcB97SzVi4rh7ciioEid_IXCr4W1s2F-JJy_F3hxt9DfFd62HwJyB9gYUorQaevG6_dHsxs0o3pudL1rdI2NrudG11tMsgfJW_n_MsUuk5D1PcQ7d_HP0C8bgBM_ |
| CitedBy_id | crossref_primary_10_1016_j_vhri_2021_03_005 crossref_primary_10_1016_j_vaccine_2020_08_028 crossref_primary_10_1111_mcn_13323 crossref_primary_10_1093_heapol_czaa149 |
| Cites_doi | 10.1371/journal.pone.0040995 10.1016/j.jclinepi.2006.08.004 10.9745/GHSP-D-14-00209 10.1186/1471-2458-7-82 10.1093/cid/cis764 10.4103/0976-500X.85933 10.7189/jogh.05.020409 10.1186/1472-698X-6-7 10.2307/3349613 10.1186/1478-7547-10-8 10.1093/heapol/15.2.230 10.2471/BLT.10.075986 10.1093/tropej/47.2.98 10.1016/j.ejca.2012.01.012 10.1093/oso/9780195108248.001.0001 10.2165/10899580-000000000-00000 10.1001/jama.2016.12195 10.1136/bmj.e940 10.1097/CCM.0b013e31821201be 10.1002/hec.1093 10.1542/peds.2010-2158 10.1186/s12962-015-0030-3 10.1093/heapol/czl029 10.1002/1097-0142(197704)39:4+<1771::AID-CNCR2820390803>3.0.CO;2-2 10.1111/j.1365-3156.2004.01381.x 10.1093/oxfordjournals.aje.a116813 10.1542/peds.2007-1939 10.1016/S0167-6296(98)00039-3 10.1093/oxfordjournals.aje.a112044 10.1371/journal.pone.0043103 10.1136/bmj.318.7191.1136 10.1186/1478-7547-1-7 10.1186/1478-7547-4-14 10.1007/s40273-012-0015-4 10.4103/2229-3485.96449 10.1136/bmj.38652.550278.7C 10.1016/S0140-6736(10)61461-4 10.2165/11585070-000000000-00000 10.7326/0003-4819-116-1-78 10.1002/hec.678 10.1371/journal.pone.0051904 10.2105/AJPH.79.3.340 10.1016/j.jclinepi.2012.06.012 10.2165/11585080-000000000-00000 10.1093/heapol/czw083 10.1016/S0140-6736(12)61959-X 10.1093/oso/9780198529446.001.0001 10.1016/j.jval.2013.02.013 10.1093/ije/9.4.361 10.1093/ije/7.4.373 10.1186/1748-5908-8-80 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2017 COPYRIGHT 2017 BioMed Central Ltd. Copyright BioMed Central 2017 |
| Copyright_xml | – notice: The Author(s) 2017 – notice: COPYRIGHT 2017 BioMed Central Ltd. – notice: Copyright BioMed Central 2017 |
| DBID | C6C AAYXX CITATION NPM 3V. 7WY 7WZ 7X7 7XB 87Z 88C 8C1 8FI 8FJ 8FK 8FL 8G5 ABUWG AFKRA AZQEC BENPR BEZIV CCPQU DWQXO FRNLG FYUFA F~G GHDGH GNUQQ GUQSH K60 K6~ K9. L.- M0C M0S M0T M2O MBDVC PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQBIZ PQBZA PQEST PQQKQ PQUKI Q9U 7X8 5PM DOA |
| DOI | 10.1186/s12962-017-0070-y |
| DatabaseName | Springer Nature OA Free Journals CrossRef PubMed ProQuest Central (Corporate) ABI/INFORM Collection ABI/INFORM Global (PDF only) Health & Medical Collection ProQuest Central (purchase pre-March 2016) ABI/INFORM Collection Healthcare Administration Database (Alumni) Public Health Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ABI/INFORM Collection (Alumni) Research Library (Alumni) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials AUTh Library subscriptions: ProQuest Central Business Premium Collection ProQuest One Community College ProQuest Central Korea Business Premium Collection (Alumni) Health Research Premium Collection ABI/INFORM Global (Corporate) Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Research Library ProQuest Business Collection (Alumni Edition) ProQuest Business Collection ProQuest Health & Medical Complete (Alumni) ABI/INFORM Professional Advanced ABI/INFORM Global ProQuest Health & Medical Collection Healthcare Administration Database Research Library Research Library (Corporate) ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) One Health & Nursing ProQuest One Business ProQuest One Business (Alumni) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) Open Access: DOAJ - Directory of Open Access Journals |
| DatabaseTitle | CrossRef PubMed Publicly Available Content Database ABI/INFORM Global (Corporate) ProQuest Business Collection (Alumni Edition) ProQuest One Business Research Library Prep ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ABI/INFORM Complete ProQuest Central ABI/INFORM Professional Advanced ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Research Library ProQuest Central (New) ABI/INFORM Complete (Alumni Edition) Business Premium Collection ABI/INFORM Global ProQuest Public Health ABI/INFORM Global (Alumni Edition) ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Health Management ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Business Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest Health Management (Alumni Edition) ProQuest One Business (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) Business Premium Collection (Alumni) MEDLINE - Academic |
| DatabaseTitleList | PubMed Publicly Available Content Database MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Public Health |
| EISSN | 1478-7547 |
| EndPage | 15 |
| ExternalDocumentID | oai_doaj_org_article_4c34693fd4084435859beacae121ce99 PMC5465559 A511367220 28603456 10_1186_s12962_017_0070_y |
| Genre | Journal Article |
| GeographicLocations | India Gujarat India |
| GeographicLocations_xml | – name: India – name: Gujarat India |
| GrantInformation_xml | – fundername: Bill and Melinda Gates Foundation funderid: http://dx.doi.org/10.13039/100000865 – fundername: ; |
| GroupedDBID | --- 0R~ 29F 2WC 44B 53G 5GY 5VS 6J9 6PF 7WY 7X7 8C1 8FI 8FJ 8FL 8G5 AAFWJ AAJSJ AASML AAWTL ABDBF ABUWG ACGFO ACGFS ACUHS ADBBV ADRAZ ADUKV AFKRA AFPKN AHBYD AHMBA AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS AQUVI AZQEC BAPOH BAWUL BCNDV BENPR BEZIV BFQNJ BMC BPHCQ BVXVI C6C CCPQU CS3 DIK DU5 DWQXO E3Z EBD EBLON EBS EJD ESX F5P FRNLG FYUFA GNUQQ GROUPED_DOAJ GUQSH GX1 H13 HMCUK HYE IAO IHR ITC K60 K6~ KQ8 M0C M0T M2O M48 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQBIZ PQBZA PQQKQ PROAC PUEGO RBZ RNS ROL RPM RSV SMD SOJ TR2 TUS UKHRP WOQ WOW XSB ~8M AAYXX AFFHD CITATION -A0 123 2VQ 3V. 4.4 ACRMQ ADINQ AHSBF ALIPV C1A C24 FRP IPNFZ NPM RIG 7XB 8FK K9. L.- MBDVC PKEHL PQEST PQUKI Q9U 7X8 5PM |
| ID | FETCH-LOGICAL-c603t-1c8dbce2f757448e93a3bd734677188136b7866e9ce2c63c867daacb0db2aa3a3 |
| IEDL.DBID | M0C |
| ISICitedReferencesCount | 6 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000403481200001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1478-7547 |
| IngestDate | Fri Oct 03 12:52:32 EDT 2025 Tue Nov 04 01:59:41 EST 2025 Fri Sep 05 08:18:27 EDT 2025 Tue Oct 14 12:41:58 EDT 2025 Tue Nov 11 09:54:25 EST 2025 Tue Nov 04 18:00:06 EST 2025 Thu Jan 02 22:39:17 EST 2025 Tue Nov 18 22:34:08 EST 2025 Sat Nov 29 03:06:11 EST 2025 Sat Sep 06 07:22:19 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Implementation science Diarrhea Developing countries Oral rehydration salts Cost-effectiveness Net-benefit regression Zinc India |
| Language | English |
| License | Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c603t-1c8dbce2f757448e93a3bd734677188136b7866e9ce2c63c867daacb0db2aa3a3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | https://www.proquest.com/docview/1915416274?pq-origsite=%requestingapplication% |
| PMID | 28603456 |
| PQID | 1915416274 |
| PQPubID | 44359 |
| PageCount | 15 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_4c34693fd4084435859beacae121ce99 pubmedcentral_primary_oai_pubmedcentral_nih_gov_5465559 proquest_miscellaneous_1908798116 proquest_journals_1915416274 gale_infotracmisc_A511367220 gale_infotracacademiconefile_A511367220 pubmed_primary_28603456 crossref_citationtrail_10_1186_s12962_017_0070_y crossref_primary_10_1186_s12962_017_0070_y springer_journals_10_1186_s12962_017_0070_y |
| PublicationCentury | 2000 |
| PublicationDate | 2017-06-08 |
| PublicationDateYYYYMMDD | 2017-06-08 |
| PublicationDate_xml | – month: 06 year: 2017 text: 2017-06-08 day: 08 |
| PublicationDecade | 2010 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | Cost effectiveness and resource allocation |
| PublicationTitleAbbrev | Cost Eff Resour Alloc |
| PublicationTitleAlternate | Cost Eff Resour Alloc |
| PublicationYear | 2017 |
| Publisher | BioMed Central BioMed Central Ltd Springer Nature B.V BMC |
| Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: Springer Nature B.V – name: BMC |
| References | R Franco (70_CR5) 2007; 7 KJ Rothman (70_CR35) 1977; 39 GD Sanders (70_CR73) 2016; 316 70_CR31 N Taffa (70_CR68) 2005; 10 CL Fischer-Walker (70_CR65) 2015; 3 MF Drummond (70_CR25) 2005 JP Grutters (70_CR45) 2013; 31 Million Death Study Collaborators (70_CR62) 2010; 376 HA Glick (70_CR21) 2011; 29 70_CR70 CLF Walker (70_CR15) 2015; 3 AE Jones (70_CR7) 2011; 39 O Miettinen (70_CR36) 1974; 100 HA Glick (70_CR23) 2011; 29 K Claxton (70_CR40) 1999; 18 S Mazumder (70_CR46) 2010; 88 70_CR27 LG Dales (70_CR32) 1978; 7 70_CR29 S Ahmed (70_CR71) 2001; 47 AB Patel (70_CR56) 2003; 1 W Gao (70_CR66) 2012; 7 70_CR61 SD Shillcutt (70_CR20) 2009; 27 R Rheingans (70_CR30) 2012; 55 BL Ramaekers (70_CR42) 2013; 16 70_CR64 70_CR63 GV Gregorio (70_CR57) 2007; 60 S Palmer (70_CR1) 1999; 318 70_CR24 SK Gupta (70_CR49) 2013 B Gitanjali (70_CR58) 2011; 2 MR Gold (70_CR26) 1996 JS Hoch (70_CR3) 2002; 11 70_CR60 S Lewycka (70_CR14) 2013; 381 SD Shillcutt (70_CR10) 2015; 19 S Greenland (70_CR33) 1980; 9 B Robberstad (70_CR53) 2004; 82 SD Shillcutt (70_CR11) 2016; 31 70_CR59 70_CR17 70_CR16 70_CR19 70_CR18 L Kumaranayake (70_CR28) 2000; 15 B Hass (70_CR48) 2012; 3 S Greenland (70_CR34) 1989; 79 70_CR52 JM Wooldridge (70_CR72) 2009 A Manasyan (70_CR6) 2011; 127 S Hounton (70_CR50) 2012; 10 S Vyas (70_CR39) 2006; 21 AD Oxman (70_CR41) 1992; 116 J Borghi (70_CR9) 2013; 8 O Sabot (70_CR43) 2012; 344 R Baltussen (70_CR47) 2006; 4 T Tan-Torres Edejer (70_CR4) 2005; 331 N Bhandari (70_CR22) 2008; 121 70_CR44 CT Sreeramareddy (70_CR69) 2012; 7 M Sculpher (70_CR2) 2006; 15 D Filmer (70_CR38) 2001; 38 S Hounton (70_CR51) 2012; 7 L Hedden (70_CR8) 2012; 48 AE LeFevre (70_CR13) 2013; 91 G Maldonado (70_CR37) 1993; 138 CT Sreeramareddy (70_CR67) 2006; 6 AB Patel (70_CR55) 2013; 66 LM Lamberti (70_CR12) 2015; 5 D Bishai (70_CR54) 2015; 13 |
| References_xml | – ident: 70_CR27 – ident: 70_CR52 – volume: 82 start-page: 523 issue: 7 year: 2004 ident: 70_CR53 publication-title: Bull WHO – volume: 7 start-page: e40995 issue: 7 year: 2012 ident: 70_CR51 publication-title: PLoS ONE doi: 10.1371/journal.pone.0040995 – volume: 60 start-page: 560 issue: 6 year: 2007 ident: 70_CR57 publication-title: J Clin Epidemiol doi: 10.1016/j.jclinepi.2006.08.004 – volume: 91 start-page: 736 year: 2013 ident: 70_CR13 publication-title: Bull WHO – volume: 3 start-page: 230 year: 2015 ident: 70_CR15 publication-title: Glob Health Sci Pract. doi: 10.9745/GHSP-D-14-00209 – volume: 7 start-page: 82 issue: 1 year: 2007 ident: 70_CR5 publication-title: BMC Public Health doi: 10.1186/1471-2458-7-82 – ident: 70_CR17 – volume: 55 start-page: S327 issue: suppl 4 year: 2012 ident: 70_CR30 publication-title: Clin Infect Dis doi: 10.1093/cid/cis764 – ident: 70_CR59 – volume: 2 start-page: 225 issue: 4 year: 2011 ident: 70_CR58 publication-title: J Pharmacol Pharmacother doi: 10.4103/0976-500X.85933 – volume: 5 start-page: 020409 issue: 2 year: 2015 ident: 70_CR12 publication-title: J Glob Health. doi: 10.7189/jogh.05.020409 – volume: 6 start-page: 7 issue: 1 year: 2006 ident: 70_CR67 publication-title: BMC Int Health Human Rights doi: 10.1186/1472-698X-6-7 – ident: 70_CR29 doi: 10.2307/3349613 – volume: 10 start-page: 8 issue: 1 year: 2012 ident: 70_CR50 publication-title: Cost Eff Resour Alloc doi: 10.1186/1478-7547-10-8 – volume: 15 start-page: 230 issue: 2 year: 2000 ident: 70_CR28 publication-title: Health Policy Plan. doi: 10.1093/heapol/15.2.230 – volume: 88 start-page: 754 issue: 10 year: 2010 ident: 70_CR46 publication-title: Bull World Health Organ doi: 10.2471/BLT.10.075986 – volume: 47 start-page: 98 issue: 2 year: 2001 ident: 70_CR71 publication-title: J Trop Pediatrics doi: 10.1093/tropej/47.2.98 – volume-title: Introductory econometrics: a modern approach year: 2009 ident: 70_CR72 – volume: 48 start-page: 1969 issue: 13 year: 2012 ident: 70_CR8 publication-title: Eur J Cancer doi: 10.1016/j.ejca.2012.01.012 – volume-title: Cost effectiveness in health and medicine year: 1996 ident: 70_CR26 doi: 10.1093/oso/9780195108248.001.0001 – volume: 27 start-page: 903 issue: 11 year: 2009 ident: 70_CR20 publication-title: Pharmacoeconomics doi: 10.2165/10899580-000000000-00000 – ident: 70_CR61 – volume: 316 start-page: 1093 issue: 10 year: 2016 ident: 70_CR73 publication-title: JAMA doi: 10.1001/jama.2016.12195 – volume: 344 start-page: e940 year: 2012 ident: 70_CR43 publication-title: BMJ doi: 10.1136/bmj.e940 – volume: 39 start-page: 1306 issue: 6 year: 2011 ident: 70_CR7 publication-title: Crit Care Med doi: 10.1097/CCM.0b013e31821201be – volume: 15 start-page: 677 year: 2006 ident: 70_CR2 publication-title: Health Econ doi: 10.1002/hec.1093 – volume: 127 start-page: e1176 issue: 5 year: 2011 ident: 70_CR6 publication-title: Pediatrics doi: 10.1542/peds.2010-2158 – volume: 13 start-page: 3 issue: 1 year: 2015 ident: 70_CR54 publication-title: Cost Eff Res Alloc doi: 10.1186/s12962-015-0030-3 – ident: 70_CR16 – volume: 21 start-page: 459 issue: 6 year: 2006 ident: 70_CR39 publication-title: Health Policy Plan doi: 10.1093/heapol/czl029 – volume: 39 start-page: 1771 issue: S4 year: 1977 ident: 70_CR35 publication-title: Cancer doi: 10.1002/1097-0142(197704)39:4+<1771::AID-CNCR2820390803>3.0.CO;2-2 – ident: 70_CR44 – volume: 3 start-page: 230 issue: 2 year: 2015 ident: 70_CR65 publication-title: Glob Health Sci Pract. doi: 10.9745/GHSP-D-14-00209 – volume: 10 start-page: 240 issue: 3 year: 2005 ident: 70_CR68 publication-title: Trop Med Int Health doi: 10.1111/j.1365-3156.2004.01381.x – volume: 138 start-page: 923 issue: 11 year: 1993 ident: 70_CR37 publication-title: Am J Epidemiol doi: 10.1093/oxfordjournals.aje.a116813 – volume: 121 start-page: e1279 issue: 5 year: 2008 ident: 70_CR22 publication-title: Pediatrics doi: 10.1542/peds.2007-1939 – volume: 38 start-page: 115 year: 2001 ident: 70_CR38 publication-title: Demography – volume: 18 start-page: 341 issue: 3 year: 1999 ident: 70_CR40 publication-title: J Health Econ doi: 10.1016/S0167-6296(98)00039-3 – ident: 70_CR31 – ident: 70_CR60 – volume: 100 start-page: 350 issue: 5 year: 1974 ident: 70_CR36 publication-title: Am J Epidemiol doi: 10.1093/oxfordjournals.aje.a112044 – volume: 7 start-page: e43103 issue: 8 year: 2012 ident: 70_CR66 publication-title: PLoS ONE doi: 10.1371/journal.pone.0043103 – volume: 318 start-page: 1136 issue: 7191 year: 1999 ident: 70_CR1 publication-title: Br Med J doi: 10.1136/bmj.318.7191.1136 – volume: 1 start-page: 7 issue: 1 year: 2003 ident: 70_CR56 publication-title: Cost Eff Res Alloc doi: 10.1186/1478-7547-1-7 – ident: 70_CR64 – ident: 70_CR19 – volume: 4 start-page: 14 issue: 1 year: 2006 ident: 70_CR47 publication-title: Cost Eff Resour Alloc doi: 10.1186/1478-7547-4-14 – volume-title: Proposed pharmacoeconomics guidelines for India (PEG-I) year: 2013 ident: 70_CR49 – volume: 31 start-page: 111 issue: 2 year: 2013 ident: 70_CR45 publication-title: Pharmacoeconomics doi: 10.1007/s40273-012-0015-4 – volume: 3 start-page: 66 issue: 2 year: 2012 ident: 70_CR48 publication-title: Perspect Clin Res doi: 10.4103/2229-3485.96449 – volume: 331 start-page: 1177 issue: 7526 year: 2005 ident: 70_CR4 publication-title: BMJ doi: 10.1136/bmj.38652.550278.7C – volume: 376 start-page: 1853 issue: 9755 year: 2010 ident: 70_CR62 publication-title: Lancet doi: 10.1016/S0140-6736(10)61461-4 – ident: 70_CR70 – volume: 29 start-page: 189 issue: 3 year: 2011 ident: 70_CR21 publication-title: Pharmacoeconomics doi: 10.2165/11585070-000000000-00000 – ident: 70_CR24 – volume: 116 start-page: 78 issue: 1 year: 1992 ident: 70_CR41 publication-title: Ann Intern Med doi: 10.7326/0003-4819-116-1-78 – volume: 11 start-page: 415 year: 2002 ident: 70_CR3 publication-title: Health Econ doi: 10.1002/hec.678 – volume: 7 start-page: e51904 issue: 12 year: 2012 ident: 70_CR69 publication-title: PLoS ONE doi: 10.1371/journal.pone.0051904 – volume: 79 start-page: 340 issue: 3 year: 1989 ident: 70_CR34 publication-title: Am J Public Health doi: 10.2105/AJPH.79.3.340 – volume: 66 start-page: 52 issue: 1 year: 2013 ident: 70_CR55 publication-title: J Clin Epidemiol doi: 10.1016/j.jclinepi.2012.06.012 – volume: 29 start-page: 287 issue: 4 year: 2011 ident: 70_CR23 publication-title: Pharmacoeconomics. doi: 10.2165/11585080-000000000-00000 – ident: 70_CR63 – volume: 31 start-page: 1411 issue: 10 year: 2016 ident: 70_CR11 publication-title: Health Policy Plan. doi: 10.1093/heapol/czw083 – volume: 381 start-page: 1721 issue: 9879 year: 2013 ident: 70_CR14 publication-title: Lancet doi: 10.1016/S0140-6736(12)61959-X – ident: 70_CR18 – volume-title: Methods for the economic evaluation of health care programs year: 2005 ident: 70_CR25 doi: 10.1093/oso/9780198529446.001.0001 – volume: 16 start-page: 855 issue: 5 year: 2013 ident: 70_CR42 publication-title: Value Health doi: 10.1016/j.jval.2013.02.013 – volume: 9 start-page: 361 issue: 4 year: 1980 ident: 70_CR33 publication-title: Int J Epidemiol doi: 10.1093/ije/9.4.361 – volume: 19 start-page: 164 year: 2015 ident: 70_CR10 publication-title: Implement Sci. – volume: 7 start-page: 373 issue: 4 year: 1978 ident: 70_CR32 publication-title: Int J Epidemiol doi: 10.1093/ije/7.4.373 – volume: 8 start-page: 1 issue: 1 year: 2013 ident: 70_CR9 publication-title: Implement Sci doi: 10.1186/1748-5908-8-80 |
| SSID | ssj0023208 |
| Score | 2.1074195 |
| Snippet | Background
This study evaluates the cost-effectiveness of the DAZT program for scaling up treatment of acute child diarrhea in Gujarat India using a... This study evaluates the cost-effectiveness of the DAZT program for scaling up treatment of acute child diarrhea in Gujarat India using a net-benefit... Background This study evaluates the cost-effectiveness of the DAZT program for scaling up treatment of acute child diarrhea in Gujarat India using a... Abstract Background This study evaluates the cost-effectiveness of the DAZT program for scaling up treatment of acute child diarrhea in Gujarat India using a... |
| SourceID | doaj pubmedcentral proquest gale pubmed crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 9 |
| SubjectTerms | Capital costs Care and treatment Caregivers Child mortality Childhood diarrhea Children & youth Cost analysis Cost control Cost-effectiveness Diarrhea Economic aspects Health Administration Health care costs Health care expenditures Health Economics Health Services Research Hypotheses India Intervention Medicine Medicine & Public Health Methods Net-benefit regression Oral rehydration salts Oral rehydration therapy Pharmacoeconomics and Health Outcomes Public Health Quality of Life Research Standard deviation Studies Trends Zinc Zinc (Nutrient) |
| SummonAdditionalLinks | – databaseName: Open Access: DOAJ - Directory of Open Access Journals dbid: DOA link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3da9UwFA8yfBBE5nfnlAiCX4S1SZukvl2nU0GGDxOGLyFJ060irfT2Dq7_nP-aJ016uZ2oL742J22Sc3I-mpPfQeiJprbiNYOdVlaU5IYVpKwMJTXXFtyHKjPFeFH4ozg-lqen5aetUl8-JyzAA4eFO8gtgwiO1VWeyhxsuyxKA8pCu4xm1pXj1b1UlFMwFUMtRlMZzzAzyQ-WYNW4T0EQxOPbkPXMCo1g_b-r5C2bdDlf8tKh6WiLjnbRjehE4kUY_E10xbW30PXwBw6Hi0W30c_DbjmQkK8RVRrWEYIEdzUGzw-DcPQ9qGPsK6pcBC7hWLoH_2haCz0q7C_x496dr6t-ohihCPCzN4svJ89xzPHCTYt7j-KB362-ekRx_KGFD7yCd-Ctc_Lp260biIFh1c0ALz8L-bgtrqdssTvo89Hbk8P3JJZrIJanbCCZlZWxjtaiEBD0uZJpZioB7BNgAGXGuBGSc1cCjeXMSi4qra1JQTa0BuK7aKftWncfYQiKuKSZyZmweV0KrZ3QogZfS9TMGp6gdGKfshHL3JfU-KbGmEZyFTiugOPKc1ytE_Ri0-V7APL4G_FrLxMbQo_BPT4AyVRRMtW_JDNBT71EKa8pYHBWxwsPnV9ZeL4ofD0dQWmaoP0ZJexwO2-eZFJFDbNUEGcX4ExTkSfo8abZ9_RZc63rVp4mlaKUWQYLdi-I8GZKVALTwHtOkJgJ92zO85a2OR_xxwuPuVfA_F5O22BrWH9a0r3_saQP0DU6bmJOUrmPdoZ-5R6iq_ZiaJb9o1EF_AKjwWKB priority: 102 providerName: Directory of Open Access Journals – databaseName: SpringerLINK Contemporary 1997-Present dbid: RSV link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3ra9UwFA86RQTxMV_VKREEXwTbpE1Sv12nU0GH6BzDLyFJ060irfT2Dq7_nP-aJ216uZ0P0K_NSZvkPNOc_A5C9zW1BS8ZaFpeUJIalpG8MJSUXFsIH4rEZP1F4bdid1ceHOTvwz3u-ZjtPh5J9pa6V2vJn87BM3GfRiCIx6ghy9PoDHg76es1fPi4v9plMRrLcHz5224TB9Tj9P9qjdfc0clUyRPnpb0b2rn0XxO4jC6GqBPPBjG5gk65ehOdexfO1TfRheHvHR4uJV1FP7abeUeGXI9gDrEO8CW4KTFEjRgEq23BlGNfjeV44DAOZX_w96q20KPAHgAAt-5oWbQjRQ9jgB--mH3ee4RDfhiuatx6BBD8avHFo5HjNzV84Bm8A6-dsY_frl1HDAyrrDp4-eGQy1vjcsw0u4Y-7bzc235NQqkHYnnMOpJYWRjraCkyARtGlzPNTCEYmHFwnjJh3AjJucuBxnJmJReF1tbEIFdaA_F1tFE3tbuJMGyouKSJSZmwaZkLrZ3QooQ4TZTMGh6heOS_sgEH3Zfj-Kr6_ZDkamCUAkYpzyi1jNDjVZdvAwjI34ife6FaEXr87v5B0x6qYA5UamFqOSuLNJYpRKwyyw24QO0SmliX5xF64EVSeSsDg7M6XJZo_MrC81nma_EISuMIbU0owTrYafMo1CpYp7mCPXoGgTgVaYTurZp9T59xV7tm4WliKXKZJLBgNwYdWE2JSmAaRN4REhPtmMx52lJXRz12eebx-jKY35NRR9aG9aclvfVP1LfRedorGSex3EIbXbtwd9BZe9xV8_Zubyx-Ak0cakA priority: 102 providerName: Springer Nature |
| Title | Cost-effectiveness analysis of the diarrhea alleviation through zinc and oral rehydration therapy (DAZT) program in rural Gujarat India: an application of the net-benefit regression framework |
| URI | https://link.springer.com/article/10.1186/s12962-017-0070-y https://www.ncbi.nlm.nih.gov/pubmed/28603456 https://www.proquest.com/docview/1915416274 https://www.proquest.com/docview/1908798116 https://pubmed.ncbi.nlm.nih.gov/PMC5465559 https://doaj.org/article/4c34693fd4084435859beacae121ce99 |
| Volume | 15 |
| WOSCitedRecordID | wos000403481200001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVADU databaseName: Open Access: BioMedCentral Open Access Titles customDbUrl: eissn: 1478-7547 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0023208 issn: 1478-7547 databaseCode: RBZ dateStart: 20030101 isFulltext: true titleUrlDefault: https://www.biomedcentral.com/search/ providerName: BioMedCentral – providerCode: PRVAON databaseName: Directory of Open Access Journals customDbUrl: eissn: 1478-7547 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0023208 issn: 1478-7547 databaseCode: DOA dateStart: 20030101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1478-7547 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0023208 issn: 1478-7547 databaseCode: M~E dateStart: 20030101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: ABI/INFORM Collection customDbUrl: eissn: 1478-7547 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0023208 issn: 1478-7547 databaseCode: 7WY dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.proquest.com/abicomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ABI/INFORM Global (OCUL) customDbUrl: eissn: 1478-7547 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0023208 issn: 1478-7547 databaseCode: M0C dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/abiglobal providerName: ProQuest – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1478-7547 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0023208 issn: 1478-7547 databaseCode: 7X7 dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: Healthcare Administration Database (Proquest) customDbUrl: eissn: 1478-7547 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0023208 issn: 1478-7547 databaseCode: M0T dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthmanagement providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1478-7547 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0023208 issn: 1478-7547 databaseCode: BENPR dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Public Health Database customDbUrl: eissn: 1478-7547 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0023208 issn: 1478-7547 databaseCode: 8C1 dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/publichealth providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 1478-7547 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0023208 issn: 1478-7547 databaseCode: PIMPY dateStart: 20090101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVPQU databaseName: Research Library customDbUrl: eissn: 1478-7547 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0023208 issn: 1478-7547 databaseCode: M2O dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/pqrl providerName: ProQuest – providerCode: PRVAVX databaseName: Springer Standard Collection customDbUrl: eissn: 1478-7547 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0023208 issn: 1478-7547 databaseCode: RSV dateStart: 20031201 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELZoywEJ8X4EyspISLwUNU_b4YK2SwuV6LIqLSxcIsdx2kUoKdlspeXP8deYcZxlt4heuPgQjxOPMx7P2ONvCHkiA5WzIoSZluSBG2Vh7CZ5FrgFkwrMh9zPYnNR-D0fDsV4nIzshtvUhlV2OtEo6rxSuEe-BX5FDMYDOFGvT3-4mDUKT1dtCo01soGWDYb07XuDhcMVBp6wJ5m-YFtTWNsYBiJwF1Fu3PnKWmQg-_9WzEsr0_moyXNHp2ZF2r3-v7zcINesLUr7rfDcJJd0eYtcbTfyaHs_6Tb5NaimjduGfVjNSKVFMqFVQcGApCBjdQ1anWJilrP2Z1ObAYj-nJQKWuQUsQBorU_med1RGEQD-uxN_-vhc2pDxeikpDWCgdC3s28ITE73SvjAK3gHXTpu775d6sbNoFvFpIGXH7dhvSUtuqCzO-Rod-dw8M61WR9cxbywcX0l8kzpoOAxB99RJ6EMs5yHoNFhHRV-yDIuGNMJ0CgWKsF4LqXKPBAxKYH4Llkvq1LfJxR8KyYCP4tCrqIi4VJqLnkBJhsvQpUxh3jd_0-VhUTHzBzfU-MaCZa2IpOCyKQoMuncIS8WTU5bPJCLiLdRqBaECOVtHlT1cWo1QxopYC0JizzyRATGq4iTDFZDqf3AVzpJHPIURTJFhQOdU9Lem6hwZOF5P8a0PDwIPIdsrlCColCr1Z00plZRTdM_ouiQx4tqbInBd6WuZkjjCZ4I34cBu9fOgQVLgYCfBka4Q_jK7FjhebWmnJwYGPMYofti4O9lN4-WuvWvIX1wMRMPyZXAzG_memKTrDf1TD8il9VZM5nWPbLGP3_BcsxNKaAUA79HNrZ3hqODntmQ6RkdYspDLIMPUD_a2x9hy4OPn34Dovh7fA |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1R3ZbtQw0CoFCSTEfQQKGAnEJauJndgOEkLLltJVlxUPi1TxYhzHaRehpGSzRctH8Qv8GuMcy24RfesDr_HY8UzmjMczCD3S1KQ8YyBpcUpJmLCIxGlCSca1AfchDZKovig8FKOR3NuLP6yhn91dGJdW2enEWlGnhXH_yDchrojAeYAg6vXhN-K6RrnT1a6FRsMWu3b-HUK26avBFnzfx5Ruvx33d0jbVYAY7rOKBEamibE0E5GA2MTGTLMkFQw0BuhpGTCeCMm5jQHGcGYkF6nWJvEBBa0BGNY9g86GIYiHSxX0-4sAj1FftiengeSbU7Cl3CU-COKq6pD5iu2rWwT8bQiWLOHxLM1jR7W1Bdy-_L_R7gq61PrauNcIx1W0ZvNr6GLzoxI396-uo1_9YlqRJq2l1fxYt5VacJFhcJAxyFBZgtXCrvHMUcPMuO1whH9McgMzUuxqHeDSHszTsoOoKzbgp1u9T-NnuE2Fw5Mcl67YCX43--IKr-NBDi94CWvgpXSC7t25rUgC28omFSy-36Qt5zjrkupuoI-nQsObaD0vcnsbYYgduaRBEjJhwiwWWluhRQYuqciYSbiH_I7flGlLvrvOI19VHfpJrhoWVcCiyrGomnvo-WLKYVPv5CTgN46JF4CuVHn9oCj3Vav5VGgAtZhlaejLEJxzGcUJWHttAxoYG8ceeuJEQDmFCpszur0XUjjKwvNe5NoOCUp9D22sQIIiNKvDHferVhFP1R_W99DDxbCb6ZILc1vMHIwvRSyDAAh2q5G5BUpUwkeDIMNDYkUaV3BeHcknB3WZ9siVJowAvxed3C5t618kvXMyEg_Q-Z3x-6EaDka7d9EFWusWTny5gdarcmbvoXPmqJpMy_u1ZsLo82mL82_ZQ85n |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3ra9UwFA86ZQjiY76qUyMIvihrkzZJ_XbdvDqcl4GbDL-ENE23K5KO3t7B9Z_zX_OkTS-38wHi1-akzeM8m5PfQeipIrpgJQVJywoSJjlNw6zISVgypcF9KOI8bS8K7_HJRBwdZfu-zumsz3bvjyS7Ow0Opck2W6dF2Ym4YFszsFLMpRTw0OHVhIuL6FLi8uhduP7p8zLioiQS_ijzt90GxqjF7P9VM6-YpvNpk-fOTluTNL7-35O5ga55bxSPOva5iS4Yu4HWP_rz9g10tfurh7vLSrfQj-1q1oRdDohXk1h5WBNclRi8SQwMV9eg4rGr0nLW7Tz25YDw96nV0KPADhgA1-ZkUdQ9RQtvgJ_vjL4cvMA-bwxPLa4dMgh-N__qUMrxroUPvIZ34JWz9_7b1jRhDsMqpw28_LjL8bW47DPQbqPD8duD7fehLwERahbRJoy1KHJtSMlTDoGkyaiiecEpqHcwqiKmLOeCMZMBjWZUC8YLpXQeAb8pBcR30JqtrLmHMARaTJA4TyjXSZlxpQxXvAT_jZdU5yxAUc8LUnt8dFem45ts4yTBZLdREjZKuo2SiwC9XHY57cBB_kb8xjHYktDhercPqvpYejUhEw1Ty2hZJJFIwJMVaZaDaVQmJrE2WRagZ449pdM-MDit_CWKyq0sPB-lrkYPJyQK0OaAErSGHjb3DC691ppJiN1TcNAJTwL0ZNnserpMPGuquaOJBM9EHMOC3e3kYTklImDTwCMPEB9IymDOwxY7PWkxzVOH45fC_F718rIyrD8t6f1_on6M1vd3xnJvd_LhAbpCWnljYSQ20VpTz81DdFmfNdNZ_ajVIT8Bq6l2CA |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cost-effectiveness+analysis+of+the+diarrhea+alleviation+through+zinc+and+oral+rehydration+therapy+%28DAZT%29+program+in+rural+Gujarat+India%3A+an+application+of+the+net-benefit+regression+framework&rft.jtitle=Cost+effectiveness+and+resource+allocation&rft.au=Shillcutt%2C+Samuel+D&rft.au=LeFevre%2C+Amnesty+E&rft.au=Fischer-Walker%2C+Christa+L&rft.au=Taneja%2C+Sunita&rft.date=2017-06-08&rft.issn=1478-7547&rft.eissn=1478-7547&rft.volume=15&rft.spage=9&rft_id=info:doi/10.1186%2Fs12962-017-0070-y&rft_id=info%3Apmid%2F28603456&rft.externalDocID=28603456 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1478-7547&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1478-7547&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1478-7547&client=summon |